Skip to main content

Leonard Greenstein

Equibles does not estimate personal net worth.

Get an email with a short summary when Carlsmed, Inc. publishes a filing, an earnings call transcript or a press release.

Get CARL alerts

About Leonard Greenstein

Leonard Greenstein is recorded as CFO at Carlsmed, Inc. (CARL). Leonard Greenstein has spoken on 3 earnings calls and 2 other investor events across 1 company, most recently for Carlsmed, Inc. on August 12, 2026. Carlsmed, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Carlsmed, Inc. includes Mike Cordonnier (CEO), Richard Heppenstall (CFO) and Jeffrey Bertolini (COO).

Leonard Greenstein on recent calls

“So Travis, you know, really everything starts with the Aprivo platform, helping surgeons achieve superior outcomes for their patients versus legacy standard of care.”
CFO, BofA Securities 2026 SMID Cap Conference ·
“Revenue for the second quarter of 2026 was $18.9 million, compared to $12.1 million in Q2 2025, representing 57% growth year over year.”
CFO, Carlsmed Second Quarter 2026 Earnings Conference Call ·
“So when you think about the longer term average revenue per procedure, we ended Q1 26 with roughly $30,000 of average revenue per procedure when you combine uh now cervical we see you know longer term and kind of the the mid the high 20s so call it 27 28 000 per revenue average revenue per procedure over time over…”
CFO, Truist Securities MedTech Conference ·
“I'll begin today with first quarter 2026 P&L highlights. Revenue for the first quarter of 2026 was $16.1 million, compared to $10.2 million in Q1 2025, representing 58% growth year over year.”
CFO, Earnings conference call (announced in 8-K) ·
“I'll begin today with fourth quarter 2025 P&L highlights. Revenue for the fourth quarter of 2025 was $15.2 million, compared with revenue of $9.4 million in Q4 2024.”
CFO, Earnings conference call (announced in 8-K) ·

Affiliation history

Company network

Leadership on record at Carlsmed, Inc.

Recent activity